Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Arthur Tzianabos | Director | 2024-01-09 | 13,037 | $0.57 | $7.44kSell |
Paul Alloway | President and Chief Operating Officer | 2024-01-03 | 7,280 | $0.57 | $4.12kSell |
Charles Michaud Jr. | Vice President Corporate Controller and Treasurer | 2024-01-03 | 1,708 | $0.57 | $975.27Sell |
Albert Seymour | President and Chief Executive Officer | 2023-09-06 | 1,448 | $1.15 | $1.67kSell |
Julie Jordan | Chief Medical Officer | 2023-08-03 | 109 | $1.39 | $151.51Sell |
Julie Jordan | Chief Medical Officer | 2023-08-03 | 436 | $1.39 | $606.04Sell |
Julie Jordan | Chief Medical Officer | 2023-08-03 | 1,308 | $1.39 | $1.82kSell |
Julie Jordan | Chief Medical Officer | 2023-08-02 | 99 | $1.31 | $129.69Sell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Arch Venture Fund Viii LP | 178.62% | 5,768,694 | $93.28M | Insider |
Temasek Holdings Private Ltd | 174.97% | 5,650,996 | $91.38M | Institution |
5am Venture Management LLC | 140.45% | 4,535,919 | $73.35M | Institution |
James E. Flynn | 126.56% | 4,087,305 | $66.09M | Insider |
Diyong Xu | 69.76% | 2,252,987 | $36.43M | Insider |
Orbimed Advisors LLC | 69.76% | 2,252,987 | $36.43M | Insider |
David S. Grayzel | 64.78% | 2,092,106 | $33.83M | Insider |
Atlas Venture Fund X LP | 64.78% | 2,092,106 | $33.83M | Insider |
Vanguard Group Inc | 60.06% | 1,939,590 | $31.36M | Institution |
Newtyn Management LLC | 43.33% | 1,399,260 | $22.63M | Institution |